ARCHIVES

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

NCI Halts Routine P01 Site Visits Due to Travel Cut

February 7, 1992

FDA, Companies Fail To Collect COI Forms, Report Says

January 16, 2009

Toxicology Program Seeks Comment On Substances.

March 23, 2001

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009